Biocorrx (OTCMKTS:BICX – Get Free Report) and Nutex Health (NASDAQ:NUTX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends.
Volatility & Risk
Biocorrx has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500. Comparatively, Nutex Health has a beta of -0.2, meaning that its stock price is 120% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Biocorrx and Nutex Health, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Biocorrx | 0 | 1 | 0 | 0 | 2.00 |
Nutex Health | 0 | 1 | 2 | 0 | 2.67 |
Insider and Institutional Ownership
5.3% of Nutex Health shares are held by institutional investors. 21.4% of Biocorrx shares are held by company insiders. Comparatively, 36.9% of Nutex Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares Biocorrx and Nutex Health”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Biocorrx | $10,000.00 | 806.40 | -$5.11 million | ($0.35) | -1.14 |
Nutex Health | $479.95 million | 1.33 | $52.18 million | $11.89 | 9.63 |
Nutex Health has higher revenue and earnings than Biocorrx. Biocorrx is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Biocorrx and Nutex Health’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Biocorrx | N/A | N/A | -130.26% |
Nutex Health | 10.76% | 42.08% | 11.80% |
Summary
Nutex Health beats Biocorrx on 12 of the 14 factors compared between the two stocks.
About Biocorrx
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
About Nutex Health
Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.